Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue
+19.2%
EPS
+64.1%
Free cash flow
−29.8%
Total debt
−5.19%

Quarter to September 2026, against a year earlier

145.49 10.63 −6.81%
Market cap
$10.8B
P/E
25.2×
Fwd P/E
24.4×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a

Insulet Corporation (PODD) Book value per share

Alert me on Book value per share

Insulet Corporation's book value per share at the end of fiscal 2025 was 21.5×, up 24.6% from 17.3× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 22.8×. Over the past ten years it has ranged from 0.6× (fiscal 2015) to 21.5× (fiscal 2025) — the current reading is the highest in ten years. Insulet Corporation ranks 20th of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 21.5× 24.57%
FY2024 17.3× 64.59%
FY2023 10.5× 52.97%
FY2022 6.9× (16.43%)
FY2021 8.2× (11.87%)
FY2020 9.3× 644.39%
FY2019 1.3× (65.24%)
FY2018 3.6× 31.86%
FY2017 2.7× 147.77%
FY2016 1.1× 83.96%

Quarterly newest first

Period Book value per share Change
Sep 2026 22.8× 10.93%
Jun 2026 20.5× 10.27%
Mar 2026 18.6× (13.59%)
Dec 2025 21.5× 9.50%
43 more quarters

Against its own ten years

Low 0.6× High 21.5×
Ten-year median 6.9×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PODD